Sterling Pharma Solutions, a Dudley, UK-headquartered CDMO of APIs, opened a pilot-plant facility in 2019 following a £6-million ($7.6-million) investment to …
The GMP manufacturing area will produce peptide APIs from gram to kilogram range for clinical Phase I and Phase II requirements with later transfer to the …
The GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements. As the project progresses …
Find Corporate Presentation details info and services of Cordenpharma in PDF document on Pharmacompass.
The GMP manufacturing area is designed to produce peptide APIs from gram to kilogram range for clinical phase 1 and 2 requirements.
Following remarkable growth, CordenPharma announces the launch of enhanced GMP capacities in Frankfurt, aiming to streamline peptide-based drug …
CordenPharma is commissioning new GMP capacities at its Frankfurt site to manufacture early clinical phase peptide APIs for pharma and biotech customers. The …
CordenPharma is a leading CDMO for GMP API manufacturing of peptides, oligos, HPAPIs and small molecules. Partner with us for your API manufacturing needs.
CordenPharma has announced the commissioning of new GMP capacities at Frankfurt to manufacture early clinical phase peptide APIs for pharma and biotech …
Our GMP sterile injectable facility provides formulation development and manufacturing for aseptic and terminal sterilization fill and finish in pre-filled Syringes (PFS), ampoules, …